TY  -  
T1  - Lääkekustannusten osuus eturauhassyövän hoidon kustannuksista ja eri hoitomuotojen vaikutus potilaiden elämänlaatuun 
SN  -  /  
UR  - URN:NBN:fi-fe201801151171; http://hdl.handle.net/10138/32812 
T3  -  
A1  - Alakoski, Anna 
A2  -  
PB  - Helsingfors universitet 
Y1  - 2012 
LA  - fin 
AB  - Prostate cancer is the most common cancer in men in Finland. Health care costs increase annually and cost of cancer is significant to the society. Because resources are scarce more information is needed about the costs of diseases as well as treatment effectiveness. In addition to clinical effectiveness it is important to assess the value of healthcare technologies from the patient's point of view by measuring the treatment's effect on patients' quality of life. 

In this thesis a literature rev... 
VO  -  
IS  -  
SP  -  
OP  -  
KW  - prostate cancer; costs; quality of life; 15D-intstrument; cost-effectiveness; eturauhassyöpä; kustannukset; elämänlaatu; 15D-mittari; kustannusvaikuttavuus; Socialfarmaci; Social Pharmacy; Sosiaalifarmasia 
N1  -   
PP  -  
ER  -